University > Therapeutic Interventions > Cytopoint/ Lokivetmab (Injectable Antibody Therapy)
Icon for To be determined.

Cytopoint/ Lokivetmab (Injectable Antibody Therapy)

Cytopoint/ Lokivetmab (Injectable Antibody Therapy) is a biologic injection that blocks itch-related proteins in dogs with allergies, providing relief for 4-8 weeks. It is administered by veterinarians and considered a safer alternative to steroids, though some holistic vets question long-term immune system effects.
Last Reviewed Date: 12/02/2025

Overview

General Health Topics

Info Health Topics related to Cytopoint/ Lokivetmab (Injectable Antibody Therapy)

Health Conditions

Info Health conditions related to Cytopoint/ Lokivetmab (Injectable Antibody Therapy)

Blog Articles

Info Articles related to Cytopoint/ Lokivetmab (Injectable Antibody Therapy)
Featured Image Link Blog Title Blog_URL_Link

Follow the Research

Info Studies providing deeper insight into Cytopoint/ Lokivetmab (Injectable Antibody Therapy)
Title Information

Dig Deeper

Info Q/A's related to Cytopoint/ Lokivetmab (Injectable Antibody Therapy)
Title URL At a Glance